The profound impact of rescheduling cannabis from Schedule I to Schedule III signifies a crucial shift in the perception of cannabis, recognizing its medical potential and solidifying its legitimacy in the financial
IDT (NYSE:IDT) reported quarterly earnings of $0.70 per share. This is a 6.06 percent increase over earnings of $0.66 per share from the same period last year. The company reported $329.00 million in sales this quarter.
Google veteran to lead cross-functional, company-wide operations building increased value for customers through best-in-class services
NEW YORK, Feb. 9, 2023 /PRNewswire/ -- Innovid Corp.